International Clinical Trial: A randomized, open-access, single-dose, two-sequence, two-cycle, cross-bioequivalence trial of minocycline Hydrochloride Capsules (50mg) under fasting and postprandial administration conditions in healthy subjects in China

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119848) titled 'A randomized, open-access, single-dose, two-sequence, two-cycle, cross-bioequivalence trial of minocycline Hydrochloride Capsules (50mg) under fasting and postprandial administration conditions in healthy subjects in China' on March 4.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: The Fifth Affiliated Hospital of Guangzhou Medical University

Condition: None

Intervention: RT group (fasting):50mg of the reference formulation (R) followed by 50mg of the test formulation (T) TR group (fed):50 mg of the subject formulation (T) followed by 50 mg of the reference formulation (R) TR g...